Prenatal diagnosis of 21-hydroxylase deficiency caused by gene conversion and rearrangements: pitfalls and molecular diagnostic solutions
- PMID: 12478627
- DOI: 10.1002/pd.467
Prenatal diagnosis of 21-hydroxylase deficiency caused by gene conversion and rearrangements: pitfalls and molecular diagnostic solutions
Abstract
Objectives: The present paper reports the prenatal diagnosis of congenital adrenal hyperplasia (CAH) in two cases of 21-hydroxylase deficiency. DNA diagnostic errors can be caused by the presence of the highly homologous 21-hydroxylase pseudogene, CYP21P, adjacent to the functional gene, CYP21. The present paper details how complex gene conversions and rearrangements between the CYP21 and CYP21P pose unique complications for prenatal diagnosis.
Methods: Analysis of eight common mutations in the 21-hydroxylase gene as well as deletion of the entire gene is accomplished using polymerase chin reaction (PCR) followed by amplified created restriction site (ACRS) or allele-specific oligohybridization (ASO) and Southern blot followed by hybridization to a CYP21-specific probe. Linkage analysis was performed using microsatellite markers flanking the CYP21 gene.
Results: The direct mutation detection assay indicated a complicated gene conversion and rearrangement in the probands of both families. Interpretation of these rearrangements made it difficult to determine whether or not the fetuses would be affected with CAH. Linkage studies revealed that each fetus had inherited both parental disease chromosomes and was therefore predicted to be affected with CAH.
Conclusion: As observed in the two reported cases, direct DNA analysis may provide limited information due to gene conversion or rearrangement between the CYP21 and CYP21P genes. These cases suggest that direct mutation detection should be supported by linkage analysis, whenever possible, to provide more comprehensive information for the family.
Copyright 2002 John Wiley & Sons, Ltd.
Similar articles
-
The implication of de novo 21-hydroxylase mutation in clinical and prenatal molecular diagnoses.Genet Test. 2005 Summer;9(2):121-5. doi: 10.1089/gte.2005.9.121. Genet Test. 2005. PMID: 15943551
-
Direct molecular diagnosis of CYP21 mutations in congenital adrenal hyperplasia.J Med Genet. 1996 May;33(5):371-5. doi: 10.1136/jmg.33.5.371. J Med Genet. 1996. PMID: 8733045 Free PMC article.
-
Molecular analysis of the CYP21 gene and prenatal diagnosis in families with 21-hydroxylase deficiency in northeastern Iran.Horm Res. 2005;63(3):119-24. doi: 10.1159/000084570. Epub 2005 Mar 17. Horm Res. 2005. PMID: 15775714
-
Mutations in steroid 21-hydroxylase (CYP21).Hum Mutat. 1994;3(4):373-8. doi: 10.1002/humu.1380030408. Hum Mutat. 1994. PMID: 8081391 Review.
-
Molecular approaches for the diagnosis of 21-hydroxylase deficiency and congenital adrenal hyperplasia.Clin Lab Med. 1996 Mar;16(1):125-37. Clin Lab Med. 1996. PMID: 8867587 Review.
Cited by
-
Pitfalls in molecular diagnosis of 21-hydroxylase deficiency in congenital adrenal hyperplasia.Adv Biomed Res. 2015 Aug 31;4:189. doi: 10.4103/2277-9175.164009. eCollection 2015. Adv Biomed Res. 2015. PMID: 26605228 Free PMC article. Review.
-
Prenatal diagnosis of steroid 21-hydroxylase-deficient congenital adrenal hyperplasia: Experience from a tertiary care centre in India.Indian J Med Res. 2017 Feb;145(2):194-202. doi: 10.4103/ijmr.IJMR_329_16. Indian J Med Res. 2017. PMID: 28639595 Free PMC article.
-
Novel method to characterize CYP21A2 in Florida patients with congenital adrenal hyperplasia and commercially available cell lines.Mol Genet Metab Rep. 2014 Aug 8;1:312-323. doi: 10.1016/j.ymgmr.2014.07.002. eCollection 2014. Mol Genet Metab Rep. 2014. PMID: 27896104 Free PMC article.
-
Genotyping of CYP21A2 for congenital adrenal hyperplasia screening using allele-specific primer extension followed by bead array hybridization.Mol Diagn Ther. 2009 Dec 1;13(6):397-405. doi: 10.1007/BF03256346. Mol Diagn Ther. 2009. PMID: 19925038
-
[Carrier screening for 223 monogenic diseases in Chinese population: a multi-center study in 33 104 individuals].Nan Fang Yi Ke Da Xue Xue Bao. 2024 Jun 20;44(6):1015-1023. doi: 10.12122/j.issn.1673-4254.2024.06.01. Nan Fang Yi Ke Da Xue Xue Bao. 2024. PMID: 38977330 Free PMC article. Chinese.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials